Le Lézard
Classified in: Health
Subject: SVY

Bone Broth Protein Supplements Lab Tested by the Consumer Wellness Center; Results Reveal Presence of Insecticides, Pharmaceuticals and Antimicrobial Preservative Chemicals Linked to Breast Cancer



TUCSON, Ariz., Oct. 6, 2017 /PRNewswire/ -- Bone broth protein products, a staple of the popular "Paleo" diet, have been laboratory tested by the non-profit Consumer Wellness Center and its associated laboratory, CWC Labs (CWClabs.com), an ISO-accredited analytical laboratory specializing in forensic food science.

Results of the tests, acquired via LC-MS-TOF analysis, reveal the presence of insecticides, pharmaceutical chemicals, antimicrobial preservative chemicals and steroidal pheromones. At least one of the chemicals detected in the products ? butylparaben ? has been linked to an increased risk of breast cancer in medical studies.

All products tested were non-organic products. Chemical identification was performed using five different analytical vectors, including accurate mass, isotopic ratios and ion fragmentation "fingerprint" analysis. A summary of the press announcement video has been posted at ConsumerWellness.org, along with highlights of the findings from the lab tests.

The findings indicate the presence of quantities of chemicals that might raise questions among health-conscious consumers. Many bone broth products are marketed as "natural" or "all natural," yet these tests prove they may contain synthetic chemicals that might pose increased risks of diseases such as breast cancer.

In a press announcement video, CWC executive director Mike Adams, who directed the scientific research, raises concern over the "lack of transparency and ethics" in the nutritional supplements industry, which he says consists of a number of highly sophisticated supplement marketing companies whose products are never tested for chemical composition.

The Consumer Wellness Center is not claiming the products pose an acute danger, nor that they violate current FDA regulations which allow unlimited quantities of pesticides and other chemicals in the U.S. food supply. Instead, the CWC announcement is aimed at providing consumers with greater transparency about what they are purchasing and consuming, especially when such products are consumed in large aggregate quantities by consumers who purchase them based on persuasive marketing that often makes questionable health claims.

Learn more at ConsumerWellness.org.

CONTACT:  

Lacey M.

inquiry@cwclabs.com

520-232-9300 x 115

SOURCE Consumer Wellness Center


These press releases may also interest you

at 02:00
Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") announced today that the results of the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the use of...

at 02:00
Interim data provides important real world insights into the treatment pathway of patients in the UK with chronic myeloid leukaemia    In patients with a suboptimal response in first line; higher rates of subsequent ELN optimal response were...

at 01:30
Capio is strengthening its involvement in the development of digital healthcare solutions by investing MSEK 49 in the new share issue of MSEK 100 that was announced by the e-health provider Doctrin today. By investing, Capio is participating in the...

at 01:23
Nordic Nanovector ASA (OSE: NANO) has presented updated results from its LYMRIT 37-01 Phase 1/2 clinical study of Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory (R/R) indolent NHL (iNHL) at the 59th Annual ASH meeting...

10 déc 2017
Blessed Herbs Cafe and Mount Zion Rastafarian Church founder and practicing Rasta George Metropoulos today announced the launch of the organization's first holiday season food and cash drive. Directly benefiting the neighborhood's less fortunate...

10 déc 2017
A new article published today in The New England Journal of Medicine shows that 42 percent of diffuse large B cell lymphoma patients treated with axicabtagene ciloleucel, offered commercially under the brand name Yescartatm, remain in remission 15...




News published on 6 october 2017 at 08:00 and distributed by: